SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CAMPO, Gianluca Calogero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.924
AS - Asia 14.213
EU - Europa 8.259
SA - Sud America 2.833
AF - Africa 259
OC - Oceania 51
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 50.553
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.260
SG - Singapore 6.394
CN - Cina 3.498
BR - Brasile 2.387
DE - Germania 1.863
IT - Italia 1.770
HK - Hong Kong 1.510
VN - Vietnam 859
GB - Regno Unito 786
FI - Finlandia 773
UA - Ucraina 702
TR - Turchia 568
PL - Polonia 452
RU - Federazione Russa 420
SE - Svezia 361
ID - Indonesia 360
CA - Canada 305
MX - Messico 302
FR - Francia 271
IN - India 249
NL - Olanda 185
AR - Argentina 170
JP - Giappone 158
ES - Italia 135
BD - Bangladesh 122
AT - Austria 120
ZA - Sudafrica 119
BE - Belgio 93
IQ - Iraq 79
EC - Ecuador 78
LT - Lituania 67
KR - Corea 56
CO - Colombia 55
CZ - Repubblica Ceca 49
PK - Pakistan 49
AU - Australia 45
IE - Irlanda 39
VE - Venezuela 39
EG - Egitto 37
CH - Svizzera 36
IR - Iran 33
UZ - Uzbekistan 33
CL - Cile 30
PY - Paraguay 28
MA - Marocco 25
AE - Emirati Arabi Uniti 24
MY - Malesia 20
PE - Perù 20
UY - Uruguay 20
SA - Arabia Saudita 18
TW - Taiwan 18
JO - Giordania 17
KE - Kenya 17
DK - Danimarca 16
AL - Albania 15
AZ - Azerbaigian 15
DZ - Algeria 15
TH - Thailandia 15
JM - Giamaica 13
PT - Portogallo 13
IL - Israele 12
KG - Kirghizistan 12
TN - Tunisia 12
KZ - Kazakistan 11
NP - Nepal 11
DO - Repubblica Dominicana 10
RO - Romania 10
RS - Serbia 10
HR - Croazia 9
LB - Libano 9
PS - Palestinian Territory 9
BG - Bulgaria 8
OM - Oman 8
PA - Panama 8
PH - Filippine 8
CY - Cipro 7
NI - Nicaragua 7
SN - Senegal 7
XK - ???statistics.table.value.countryCode.XK??? 7
ET - Etiopia 6
LI - Liechtenstein 6
MD - Moldavia 6
NZ - Nuova Zelanda 6
SK - Slovacchia (Repubblica Slovacca) 6
BH - Bahrain 5
HU - Ungheria 5
MK - Macedonia 5
NO - Norvegia 5
TT - Trinidad e Tobago 5
BN - Brunei Darussalam 4
CG - Congo 4
CI - Costa d'Avorio 4
EU - Europa 4
LV - Lettonia 4
SI - Slovenia 4
BW - Botswana 3
CR - Costa Rica 3
GT - Guatemala 3
GY - Guiana 3
HN - Honduras 3
Totale 50.495
Salva come PNG Salva come JPEG
Città #
Singapore 3.403
Ashburn 3.143
Fairfield 2.306
Woodbridge 1.817
Hong Kong 1.483
Santa Clara 1.369
Dallas 1.317
Beijing 1.266
Houston 1.222
Chandler 1.034
Munich 1.028
Seattle 978
Wilmington 853
Ann Arbor 809
Cambridge 767
Jacksonville 761
Los Angeles 574
New York 529
Warsaw 427
Helsinki 395
Ferrara 344
Izmir 341
Princeton 326
Jakarta 288
Ho Chi Minh City 282
Nanjing 271
Shanghai 265
São Paulo 261
Milan 231
San Diego 207
Mexico City 195
Turku 187
London 172
Chicago 168
Hanoi 155
Boardman 143
Tokyo 139
Bologna 123
Hefei 121
Brooklyn 114
Buffalo 111
Nuremberg 107
Montreal 105
Denver 103
Frankfurt am Main 96
Rio de Janeiro 93
Brussels 91
Moscow 90
Boston 88
Toronto 88
Chennai 86
Orem 86
Phoenix 85
Stockholm 85
Atlanta 83
Bremen 80
Shenyang 78
Tianjin 76
San Francisco 75
Falkenstein 73
Nanchang 72
Poplar 70
Johannesburg 66
Rome 65
The Dalles 65
Redwood City 64
Falls Church 63
Washington 62
Amsterdam 58
Manchester 57
Jiaxing 55
Belo Horizonte 51
Columbus 51
Council Bluffs 50
Ankara 48
Haiphong 48
Salt Lake City 45
Changsha 44
Mountain View 44
Mumbai 43
Lappeenranta 41
Hebei 40
Dong Ket 39
Brasília 38
Redondo Beach 37
Ottawa 36
Vienna 36
Addison 34
San Mateo 34
Dublin 32
Norwalk 32
Querétaro 32
Biên Hòa 31
Goiânia 31
Guangzhou 31
Assago 30
Da Nang 30
Jinan 30
Charlotte 29
Curitiba 29
Totale 33.386
Salva come PNG Salva come JPEG
Nome #
1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a FO-ATP Synthase c Subunit Glu119-Independent Mechanism That Prevents Oligomycin A-Related Side Effects 946
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology 384
A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial 371
Physical activity intervention for elderly patients with reduced physical performance after acute coronary syndrome (HULK study): Rationale and design of a randomized clinical trial 334
Effectiveness and safety of the ABSORB bioresorbable vascular scaffold for the treatment of coronary artery disease: Systematic review and meta-analysis of randomized clinical trials 326
Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation 320
Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease 297
Exercise Intervention to Improve Functional Capacity in Older Adults After Acute Coronary Syndrome 277
Molecular identity of the mitochondrial permeability transition pore and its role in ischemia-reperfusion injury 258
Atrial Longitudinal Strain Predicts New-Onset Atrial Fibrillation: A Systematic Review and Meta-Analysis 255
Diagnostic accuracy of baseline troponin and troponin change for the diagnosis of myocardial infarction complicated with heart failure 254
Evolving Routine Standards in Invasive Hemodynamic Assessment of Coronary Stenosis: The Nationwide Italian SICI-GISE Cross-Sectional ERIS Study 252
Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction 247
How the functional assessment of culprit and non-culprit lesions may improve stratification and treatment of STEMI patients 245
Prospective identification of stent fracture by enhanced stent visualization system during percutaneous coronary intervention 233
Fo ATP synthase C subunit serum levels in patients with ST-segment Elevation Myocardial Infarction: Preliminary findings 231
Amino terminal pro brain natriuretic peptide predicts all-cause mortality in patients with chronic obstructive pulmonary disease: Systematic review and meta-analysis 230
Bioresorbable Scaffold vs. Second Generation Drug Eluting Stent in Long Coronary Lesions requiring Overlap: A Propensity-Matched Comparison (the UNDERDOGS study) 228
Antiplatelet Treatment Reduces All-Cause Mortality in COPD Patients: A Systematic Review and Meta-Analysis 225
Factor XI rs2036914 gene polymorphism and occurrence of adverse events after percutaneous coronary intervention. A prospective evaluation. 223
Poor response to clopidogrel: current and future options for its management 222
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial 214
The use of nutraceuticals to counteract atherosclerosis: The role of the Notch pathway 213
Medical and interventional management of patients with severe thrombocytopenia undergoing percutaneous coronary intervention 208
Tissue factor and coagulation factor VII levels during acute myocardial infarction: Association with genotype and adverse events 206
Inhaled corticosteroid/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients 205
Translating Evidence from Clonal Hematopoiesis to Cardiovascular Disease: A Systematic Review 205
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 204
Bleeding Risk Scores and Scales of Frailty for the Prediction of Haemorrhagic Events in Older Adults with Acute Coronary Syndrome: Insights from the FRASER study 204
Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: A meta-analysis of randomized clinical trials 203
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 201
The frailty in elderly patients receiving cardiac interventional procedures (FRASER) program: rational and design of a multicenter prospective study 201
High-dose BoluS TiRofibAn and Sirolimus eluting STEnt versus abiciximab and bare metal stent in acute MYocardial infarction (STRATEGY) study - Protocol design and demography of the first 100 patients 199
Mechanistic role of mPTP in ischemia-reperfusion injury 197
Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients with ST-Segment-Elevation Myocardial Infarction and Multivessel Disease 195
SERPINA1 Gene Promoter Is Differentially Methylated in Peripheral Blood Mononuclear Cells of Pregnant Women 195
The assessment of scales of frailty and physical performance improves prediction of major adverse cardiac events in older adults with acute coronary syndrome 192
Characterization of Dermal Stem Cells of Diabetic Patients 188
The Mitochondrial Permeability Transition Pore 187
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Can we improve myocardial protection during ischaemic injury? 186
Nutritional status and all-cause mortality in older adults with acute coronary syndrome 185
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 184
Kounis-Zavras syndrome presenting with ventricular arrhythmias and cardiogenic shock 182
C subunit of F1/FO-ATP synthase as target for preventing the detrimental effect of myocardial ischemia/reperfusion injury 179
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history 178
Grip strength predicts cardiac adverse events in patients with cardiac disorders: An individual patient pooled meta-analysis 177
Comparison of Verapamil versus Heparin as Adjunctive Treatment for Transradial Coronary Procedures: The VERMUT Study 177
Short Physical Performance Battery and all-cause mortality: Systematic review and meta-analysis 176
BRS implantation in long lesions requiring device overlapping: Myth or reality? 176
1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI 175
Impact of proton pump inhibitors on clinical outcomes in patients treated with a 6- or 24-month dual-antiplatelet therapy duration: Insights from the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia studY trial 175
Ticagrelor improves endothelial function by decreasing circulating Epidermal Growth Factor (EGF) 174
Diagnostic performance of in-procedure angiography-derived quantitative flow reserve compared to pressure-derived fractional flow reserve: The FAVOR II Europe-Japan study 174
The in vitro effects of verbascoside on human platelet aggregation 173
Notch Signaling Regulates Immune Responses in Atherosclerosis 173
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting 172
Adenosine-Free Indexes vs. Fractional Flow Reserve for Functional Assessment of Coronary Stenoses: Systematic Review and Meta-Analysis 171
Reperfusion Damage - A Story of Success, Failure, and Hope 170
Blood Interferon-α Levels and Severity, Outcomes, and Inflammatory Profiles in Hospitalized COVID-19 Patients 170
Fractional flow reserve: Current applications and overview of the available data 169
In Vitro Characterization of Circulating Endothelial Progenitor Cells Isolated from Patients with Acute Coronary Syndrome 169
Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention 169
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study 168
Fractional flow reserve evaluation and chronic kidney disease: Analysis from a multicenter Italian registry (the FREAK study) 168
Context-dependent function of ROS in the vascular endothelium: The role of the Notch pathway and shear stress 168
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting 167
Relationship between paraoxonase Q192R gene polymorphism and on-clopidogrel platelet reactivity over time in patients treated with percutaneous coronary intervention 167
Occurrence, causes, and outcome after switching from ticagrelor to clopidogrel in a real-life scenario: data from a prospective registry 165
Direct oral anticoagulants for the treatment of left ventricular thrombosis: an updated systematic review and meta-analysis 163
Impact of a recent hospitalization on treatment and prognosis of ST-segment elevation myocardial infarction 163
A serum proteome signature to predict mortality in severe COVID-19 patients 163
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach 163
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention 162
Predicting return to work after acute myocardial infarction: Socio-occupational factors overcome clinical conditions 162
Impact of COPD on Long-term Outcome After ST-Segment Elevation Myocardial Infarction Receiving Primary Percutaneous Coronary Intervention 162
A naturally occurring mutation in ATP synthase subunit c is associated with increased damage following hypoxia/reoxygenation in STEMI patients 162
Different clinical models of CD34 plus cells mobilization in patients with cardiovascular disease 161
CHA2DS2-VASc score predicts atrial fibrillation recurrence after cardioversion: systematic review and individual patient pooled meta-analysis 161
Short-versus long-term duration of dual-antiplatelet therapy after coronary stenting: A randomized multicenter trial 160
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation. 159
A Patient-Level Pooled Analysis Assessing the Impact of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) Score on 1-Year Clinical Outcomes in 6,508 Patients Enrolled in Contemporary Coronary Stent Trials 159
Clinical outcomes in patients with ST-segment elevation myocardial infarction treated with everolimus-eluting stents versus bare-metal stents (EXAMINATION): 5-year results of a randomised trial 158
Sex-specific benefits of sirolimus-eluting stent on long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study trial 158
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 157
Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies 157
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry 156
Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated with Second-Generation Drug-Eluting Stents 155
Factor XIIIA V34L and Factor XIIIB H95R Gene Polymorphisms: Effects on the Risk of Myocardial Infarction and on Survival. 154
Platelet aggregation values in patients with cardiovascular risk factors are reduced by verbascoside treatment. A randomized study 154
Antithrombotic management and 1-year outcome of patients on oral anticoagulation undergoing coronary stent implantation (from the registro regionale angioplastiche Emilia-Romagna registry) 153
Angio-based index of microcirculatory resistance for the assessment of the coronary resistance: A proof of concept study 153
Tissue Factor and Coagulation Factor VII Levels during Acute Myocardial Infarction Contribute to Predict Mortality and re-infarction. 152
Relevance of gender in patients with acute myocardial infarction undergoing coronary interventions 152
Fractional flow reserve implementation in daily clinical practice: A European survey 152
Specific properties and effect of perindopril in controlling the renin-angiotensin system 151
Effectiveness of a novel nutraceutical compound containing red yeast rice, polymethoxyflavones and antioxidants in the modulation of cholesterol levels in subjects with hypercholesterolemia and low-moderate cardiovascular risk: The NIRVANA study 151
Exercise intervention improves quality of life in older adults after myocardial infarction: randomised clinical trial 151
Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates 149
The impact of the 3-year ABSORB II trial results on my clinical practice: An Italian survey 149
Totale 20.060
Salva come PNG Salva come JPEG
Categoria #
all - tutte 280.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.903
Totale 282.889
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.467 0 0 0 0 0 300 166 498 174 541 536 252
2021/20223.161 274 287 207 148 146 163 193 195 142 239 337 830
2022/20232.784 340 126 141 235 406 396 177 251 360 71 191 90
2023/20242.794 169 292 130 91 214 490 132 281 68 128 142 657
2024/202512.666 313 330 920 586 1.425 1.211 806 708 2.320 1.302 1.514 1.231
2025/202617.032 2.969 1.574 3.299 3.858 4.751 581 0 0 0 0 0 0
Totale 51.774